Proatherogenic role of elevated CE transfer from HDL to VLDL1 and dense LDL ia type 2 diabetes impact of the degree of triglyceridemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 2, 2001, Pages 282-288

  Guérin, Maryse ^a   Le Goff, Wilfried ^a   Lassel, Taous S ^a   Van Tol, Arie ^b   Steiner, George ^c   Chapman, M John ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cholesteryl ester transfer protein; Lipoprotein subfractions; Phospholipid transfer protein; Reverse cholesterol transport; Type 2 diabetes

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; CARRIER PROTEIN; CETP PROTEIN, HUMAN; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; TRIACYLGLYCEROL BLOOD LEVEL; ARTERIOSCLEROSIS; BLOOD; DIET RESTRICTION; METABOLISM; MIDDLE AGED;

ADULT; ARTERIOSCLEROSIS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLYCOPROTEINS; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHOLIPIDS; TRIGLYCERIDES;

EID: 0034746490     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.2.282     Document Type: Article

References (30)

1. Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: Post-prandial metabolism and relation to premature atherosclerosis
2. The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles
3. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects
4. Lipoprotein heterogeneity and apolipoprotein B metabolism
5. An overview of reverse cholesterol transport
6. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidemia
7. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects
8. 1 particles
9. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum
10. A new in vitro method for the simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apoB-containing lipoprotein subspecies: Identification of preferential cholesteryl ester acceptors in human plasma
11. Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects
12. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein in plasma
13. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia: Relation to cholesteryl ester transfer protein activity and other lipoprotein variables
14. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: Its role in the inhibition of cholesteryl ester transfer
15. Human noninsulin-dependent diabetes: Identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E
16. Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes
17. Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in type II diabetics and normal controls
18. Accelerated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus
19. Plasma cholesteryl ester transfer in patients with non-insulin dependent diabetes mellitus
20. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (type 2 diabetes)
21. Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus
22. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in type 2 diabetes: Relationship to serum lipoproteins A-I and A-II
23. Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in type 2 diabetes
24. Elevated plasma cholesteryl ester transfer in type 2 diabetes: Relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein
25. Effect of adiposity on plasma lipid transfer protein activities: A possible link between insulin resistance and high density lipoprotein metabolism
26. Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease
27. Decreased ability of high density lipoproteins to transfer cholesterol esters in non-insulin-dependent diabetes mellitus
28. Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma
29. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA
30. Treatment of lipid disorders in non-insulin-dependent diabetes mellitus